FindTrial
Sign In

Effect of malaria or dengue in COVID-19 patients.

Clinical Presentations and treatment outcomes in COVID-19 patients with Co-infection of Vector Borne Diseases (Malaria or Dengue) in TNMC and BYL Nair Charitable Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029772
Enrollment
200
Registered
2020-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 3: A90- Dengue fever [classical dengue] Health Condition 4: B50- Plasmodium falciparum malaria Health Condition 5: B51- Plasmodium vivax malaria

Interventions

Control Intervention1: Nil: Nil

Sponsors

DrNiraj Mahajan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Medical case records of patients with Co-infection of malaria and dengue with COVID-19 admitted at Nair hospital from 1st March till 30th October 2020.

Exclusion criteria

Exclusion criteria: Pregnant females will be excluded.

Design outcomes

Primary

MeasureTime frame
1. Socio-demographic, epidemiological and clinical characteristics of patients with co-infection of malaria or dengue with COVID-19. 2.Viral clearance of SARS-CoV-2 infection. 3.Outcomes in patients. 4.Response to treatment. 5. Reinfection or readmission will be analysed.Timepoint: 8 months—

Secondary

MeasureTime frame
1.Reinfection or readmission will be analysed.Timepoint: 8 months—

Countries

India

Contacts

Public ContactDrNiraj Mahajan

TNMC and BYL Nair hospital

nirajdr@hotmail.com09004696920

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026